lamdis

How to appeal a Saxenda denial

Reviewed · 19 sources

The short answer

Most Saxenda denials come from one of two places. Either the plan excludes weight-loss drugs, which an appeal rarely changes, or the plan covers them but says you did not meet its prior-authorization criteria, such as a BMI cutoff or proof of diet changes. Read the letter to find out which, then send the records that match the criteria or ask your employer and the manufacturer about other options.

The appeal at a glance
  1. StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
  2. Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
  3. Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.

Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.

What Saxenda is approved for

Saxenda (liraglutide) is approved for weight management. The current FDA label lists two groups, in combination with a reduced-calorie diet and more physical activity:

  • Adults and children 12 and older with obesity who weigh more than 60 kg (about 132 pounds).
  • Adults with overweight and at least one weight-related condition.

It has the same active ingredient as the diabetes drug Victoza, at a higher dose. That matters because many plans cover diabetes drugs and exclude weight-loss drugs. One insurer's policy lists weight loss as not covered under its diabetes GLP-1 rules, because those drugs are not FDA-approved for weight loss in people without type 2 diabetes.

Why plans deny Saxenda

The plan excludes weight-loss drugs. Many job-based plans do. In KFF's 2026 employer survey, 18 percent of firms with 200 or more workers covered GLP-1 drugs for weight loss.

Prior-authorization criteria were not met. A 2024 Peterson-KFF review found that every Marketplace plan covering weight-loss drugs required prior authorization, and most set quantity limits. One insurer's September 2026 Saxenda policy for employers that add weight-loss coverage asks for:

The renewal was denied. The prescribing information says to stop liraglutide if an adult has not lost at least 4 percent of starting weight after 16 weeks, and plans use that as a renewal test.

The plan prefers another drug. A plan may cover a generic liraglutide or a different weight-loss drug and leave Saxenda off. That is a formulary decision with its own exception process.

Exclusion or prior-authorization denial: how to tell

Job-based plans must name the specific plan provision behind a denial.

  • "Excluded," "not a covered benefit" or "weight loss drugs are not covered" means an exclusion.
  • "Criteria not met" or "prior authorization required" means the plan covers the drug but wanted more proof. You can ask for a free copy of the criteria. See prior authorization denials.
  • "Non-formulary" means the plan covers weight-loss drugs but not this one.

Check the “Services Your Plan Generally Does NOT Cover” section of your Summary of Benefits and Coverage. One insurer's policy notes that the plan document always wins when it conflicts with the insurer's clinical rules. If your plan excludes weight-loss drugs, an appeal arguing medical need has no plan rule to point to; see appealing an exclusion.

What the appeal and doctor's letter should show

When the denial says criteria were not met, ask your doctor for a letter of medical necessity that answers each criterion with dated records:

  • Your starting height, weight and BMI, measured before any GLP-1 drug.
  • Each weight-related diagnosis, with the diagnosis code your doctor uses.
  • Dates of the diet, exercise or behavior program you tried and what happened.
  • Past weight-loss drugs with doses, dates and results or side effects.
  • For a renewal, weights showing your percent change since you started.

Ask the plan for the written criteria it used. Job-based plans must name the specific plan provision behind a denial and give you a free copy of any criteria they relied on. File the internal appeal within 180 days of the denial.

If Saxenda is not on the drug list, ask for a formulary exception instead of, or alongside, the appeal. Your doctor generally confirms that covered drugs have not worked, will not work as well, or are likely to cause harm. Individual and small-group plans must decide a standard request within 72 hours and an expedited one within 24 hours, and a denial can go to an independent reviewer. See formulary exception letters.

If the plan upholds a denial that turned on medical judgment, you can ask for external review within 4 months of the final decision. Your insurer has to accept the reviewer’s decision.

Medicare and Medicaid

Federal law keeps out of Part D the drug uses that Medicaid may exclude, and that list includes agents used for weight loss. Medicare's temporary GLP-1 Bridge, which runs from July 1, 2026, through December 31, 2027, covers a short list: Foundayo, Wegovy and the Zepbound KwikPen. Saxenda is not on it. If you have Medicare, ask your doctor whether a drug on that list fits. See Part D appeals.

State Medicaid coverage of GLP-1 drugs for obesity is optional; 13 state programs covered them as of January 2026. Medicaid programs may require prior authorization for any covered drug. See Medicaid appeals.

Novo Nordisk runs NovoCare for support and savings information.

Questions people ask

Why did insurance deny Saxenda?

Usually because the plan excludes weight-loss drugs, or because the prior-authorization request did not show the plan's criteria, such as a BMI threshold or months of diet changes. The denial letter has to name the plan provision it relied on.

Can I appeal if my plan excludes weight-loss drugs?

You can file, but if the plan document excludes the drug, the appeal has no plan rule to point to. Ask your employer's benefits team about coverage, ask whether a formulary exception is possible, or look at manufacturer support.

Why was my Saxenda renewal denied?

Renewals often require proof the drug is working. The prescribing information says to stop it if an adult has not lost at least 4 percent of starting weight after 16 weeks. Send dated weights from before you started and from today.

Insurance stopped covering Saxenda after I'd been on it. What can I do?

First find out why: a lapsed prior authorization, a renewal that asked for proof the drug is working, or a drug-list change. Ask your doctor to resubmit with current records. In individual and small-group plans, being in the middle of a course of treatment on a non-formulary drug qualifies for a 24-hour expedited exception. Medicare drug plans must offer a temporary supply in the first 90 days under a new plan, and that process also covers current enrollees affected by formulary changes.

Does Medicare cover Saxenda?

Part D cannot cover drugs used for weight loss, and Saxenda is not on the Medicare GLP-1 Bridge list.

What if my Saxenda appeal is denied?

If the denial turned on medical judgment, you can ask for external review by an independent reviewer within 4 months of the plan's final decision. A denied formulary exception in an individual or small-group plan can also go to independent review. With Medicare Part D, if the plan upholds its denial you have 60 days to ask a Part D Independent Review Entity to reconsider; see Part D appeals.

Sources

  1. National Library of Medicine (DailyMed): SAXENDA (liraglutide) injection prescribing information (DailyMed)Adults and pediatric patients aged 12 years and older with body weight greater than 60 kg and obesity
  2. Cigna Healthcare: Drug Coverage Policy IP0701: Diabetes – Glucagon-Like Peptide-1 Agonists for Employer Plans (effective 06/15/2026)Saxenda (liraglutide subcutaneous injection) contains the same chemical entity as liraglutide (Victoza, generic) and is indicated at a higher dose for chronic weight management.
  3. KFF: 2026 Employer Health Benefits SurveyThe overall percentage of firms with 200 or more workers that cover GLP-1 agonists for weight loss (18%) is similar to the percentage last year (19%) and two years ago
  4. Peterson-KFF Health System Tracker: Insurer strategies to control costs associated with weight loss drugsAll plans covering the drugs approved for weight loss require prior authorization. Similarly, quantity limits are imposed in most plans among those including these drugs on formulary.
  5. Cigna Healthcare: Drug Coverage Policy BEO007: Liraglutide Benefit Exclusion Overrides Policy BMI ≥ 32 (effective 09/01/2026)At baseline, patient had a BMI ≥ 32 kg/m2 [documentation required]
  6. eCFR (Office of the Federal Register): 29 CFR 2560.503-1 -- Claims procedureReference to the specific plan provisions on which the determination is based
  7. Centers for Medicare & Medicaid Services: Summary of Benefits and Coverage template (accessible format)Services Your Plan Generally Does NOT Cover (Check your policy or plan document for more information and a list of any other excluded services.)
  8. HealthCare.gov: Internal appealsYou must file your internal appeal within 180 days (6 months) of receiving notice that your claim was denied.
  9. HealthCare.gov: Getting prescription medicationsAll other drugs covered by the plan haven’t been or won’t be as effective as the drug you’re asking for
  10. eCFR (Office of the Federal Register): 45 CFR 156.122 -- Prescription drug benefitsA health plan must make its determination on a standard exception and notify the enrollee or the enrollee's designee and the prescribing physician (or other prescriber, as appropriate) of its coverage determination no later than 72 hours following receipt of the request.
  11. HealthCare.gov: External ReviewYou must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
  12. Legal Information Institute, Cornell Law School: 42 U.S. Code § 1395w-102 - Prescription drug benefitswhich may be excluded from coverage or otherwise restricted under section 1396r–8(d)(2) of this title
  13. Legal Information Institute, Cornell Law School: 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugs(A) Agents when used for anorexia, weight loss, or weight gain.
  14. Medicare.gov: Weight loss drugsStarting July 1, 2026, Medicare covers these GLP-1 drugs:
  15. KFF: Medicaid Coverage of and Spending on GLP-1sMedicaid coverage of GLP-1 drugs for obesity treatment is optional for states, while coverage for other indications (diabetes, cardiovascular disease, and sleep apnea) is required.
  16. Novo Nordisk: Support Starts Here for Patients Taking Novo Medicines | Novocare®offers the guidance, savings, and support you need to keep moving forward
  17. eCFR (Office of the Federal Register): 42 CFR 423.120 -- Access to covered Part D drugsEnsure access to a temporary supply of drugs within the first 90 days of coverage under a new plan.
  18. Medicare.gov: Appeals in a Medicare drug planyou’ll have 60 days to file a Standard Reconsideration with a Part D Independent Review Entity (IRE) to start a level 2 review
  19. Centers for Medicare & Medicaid Services: Medicare GLP-1 BridgeThe Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027.

This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.